Swiss National Bank’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-45,100
| Closed | -$818K | – | 2547 |
|
|
2020
Q3 | $818K | Hold |
45,100
| – | – | ﹤0.01% | 2195 |
|
|
2020
Q2 | $618K | Buy |
45,100
+8,700
| +24% | +$119K | ﹤0.01% | 2326 |
|
|
2020
Q1 | $521K | Buy |
36,400
+800
| +2% | +$11.5K | ﹤0.01% | 2158 |
|
|
2019
Q4 | $603K | Buy |
35,600
+800
| +2% | +$13.6K | ﹤0.01% | 2367 |
|
|
2019
Q3 | $536K | Buy |
34,800
+1,500
| +5% | +$23.1K | ﹤0.01% | 2342 |
|
|
2019
Q2 | $781K | Buy |
33,300
+800
| +2% | +$18.8K | ﹤0.01% | 2247 |
|
|
2019
Q1 | $921K | Buy |
32,500
+2,200
| +7% | +$62.3K | ﹤0.01% | 2108 |
|
|
2018
Q4 | $913K | Buy |
30,300
+2,000
| +7% | +$60.3K | ﹤0.01% | 2054 |
|
|
2018
Q3 | $991K | Hold |
28,300
| – | – | ﹤0.01% | 2144 |
|
|
2018
Q2 | $671K | Hold |
28,300
| – | – | ﹤0.01% | 2358 |
|
|
2018
Q1 | $725K | Hold |
28,300
| – | – | ﹤0.01% | 2262 |
|
|
2017
Q4 | $491K | Buy |
+28,300
| New | +$491K | ﹤0.01% | 2414 |
|